Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Assessment of response in multiple myeloma: next steps
Do gene mutations impact clinical outcome in elderly acute myeloid leukemia (AML) patients?
Phase II trial of sorafenib plus standard therapy in newly diagnosed acute myeloid leukaemia
Highlights from EBMT 2016: Immunotherapy